Acute Kidney Injury Following Exposure to Calcineurin Inhibitors in a Patient with Idiopathic Membranous Nephropathy.
Journal
Drug safety - case reports
ISSN: 2199-1162
Titre abrégé: Drug Saf Case Rep
Pays: Switzerland
ID NLM: 101674544
Informations de publication
Date de publication:
05 Oct 2019
05 Oct 2019
Historique:
entrez:
7
10
2019
pubmed:
7
10
2019
medline:
7
10
2019
Statut:
epublish
Résumé
Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome in non-diabetic adult patients; 75% of adult patients with MN suffer from primary idiopathic membranous nephropathy (IMN). The treatment of choice is immunosuppressive therapy, with a combination of steroids and cyclophosphamide (CYF) or chlorambucil or, as second-line treatment, calcineurin inhibitors (CNIs). One of the main concerns associated with the usage of CNIs is their potential to induce nephrotoxicity. We report a case of acute kidney injury that developed on two separate occasions within days of the administration of CNIs in a 57-year-old male patient treated for MN. The patient was qualified for first-line treatment with prednisone and CYF. Due to insufficient response and bad tolerance of CYF infusions, the immunosuppressive regimen was modified and CNIs were introduced, starting with cyclosporine A (CsA). On the third day of treatment, a severe decrease in diuresis and kidney function occurred and CsA was discontinued, resulting in a return to baseline kidney function. After 2 months, the situation repeated after attempting to introduce tacrolimus.
Identifiants
pubmed: 31587119
doi: 10.1007/s40800-019-0103-x
pii: 10.1007/s40800-019-0103-x
pmc: PMC6778568
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9Références
Clin Nephrol. 2007 Jun;67(6):335-40
pubmed: 17598367
Semin Nephrol. 2003 Jul;23(4):400-5
pubmed: 12923729
J Am Soc Nephrol. 1990 Jul;1(1):76-83
pubmed: 2104254
J Am Soc Nephrol. 2010 Apr;21(4):697-704
pubmed: 20110379
Am J Kidney Dis. 1992 Nov;20(5):472-81
pubmed: 1442759
Transplantation. 1999 Dec 15;68(11):1746-53
pubmed: 10609952
Kidney Int. 2012 Oct;82(8):840-56
pubmed: 22895519
Nephrology (Carlton). 2016 Feb;21(2):139-46
pubmed: 26205759
Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:853-9
pubmed: 3991583
Adv Chronic Kidney Dis. 2006 Jan;13(1):47-55
pubmed: 16412970
Kidney Int. 2004 Jun;65(6):2071-80
pubmed: 15149320
Lancet. 2013 Mar 2;381(9868):744-51
pubmed: 23312808
N Engl J Med. 1989 Dec 21;321(25):1725-38
pubmed: 2687689
Clin Nephrol. 1998 Jun;49(6):356-63
pubmed: 9696431
J Am Soc Nephrol. 1991 Aug;2(2 Suppl 1):S45-52
pubmed: 1932643
J Am Soc Nephrol. 2012 Oct;23(10):1617-30
pubmed: 22859855
N Engl J Med. 2003 Sep 4;349(10):931-40
pubmed: 12954741
BMC Nephrol. 2017 Jan 5;18(1):2
pubmed: 28056860
Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508
pubmed: 19218475
BMJ. 2005 Oct 8;331(7520):810
pubmed: 16157605
Rev Prat. 2003 Nov 30;53(18):2033-8
pubmed: 15008218
J Exp Med. 1991 Mar 1;173(3):619-28
pubmed: 1997649
Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii209-ii218
pubmed: 28339709
BioDrugs. 1999 Nov;12(5):327-41
pubmed: 18031186
JAMA. 2014 Jun 25;311(24):2518-2531
pubmed: 24892770